Delivery Order SPE2DB22D3016-SPE2DB25FBJE9
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,789.72 for 500 tablets of Topiramate 25 mg, with a completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.43 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of August 28, 2025. This competitive award, executed on August 27, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.61 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg. The contract, which became effective on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed price pricing and was awarded without a set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.72 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units, valued at $2,393.22 with a firm fixed-price structure. This award represents a non-competed delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $4,748.01 and an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,580.74 to AmerisourceBergen Drug Corp for the supply of Topiramate 50 mg tablets (1,000 count) under a firm fixed price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $2,278.74 and an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside delivery order executed under a competitive procurement process. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,882.48 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Topiramate ER 25 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations center. This...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJE9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,564.11 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and was awarded on September 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare programs globally. The Topiramate supply supports the Defense Health Agency and other government healthcare systems' medical supply chain needs, with the company demonstrating consistent capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains and product categories.